Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-05-28

Clinical Trial Update: Zemedy Application for Irritable Bowel Syndrome [NA]

View source ↗

Summary

A Stanford-sponsored trial of Zemedy for irritable bowel syndrome has been terminated, with results posted on 2025-05-28.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Stanford University | Conditions: IBS - Irritable Bowel Syndrome | NA | Status: TERMINATED | Results posted: 2025-05-28